| Literature DB >> 24822211 |
Vanessa L Koga1, Geizecler Tomazetto1, Paula S Cyoia1, Meiriele S Neves1, Marilda C Vidotto1, Gerson Nakazato1, Renata K T Kobayashi1.
Abstract
Extraintestinal pathogenic Escherichia coli (ExPEC) is one of the main etiological agents of bloodstream infections caused by Gram-negative bacilli. In the present study, 20 E. coli isolates from human hemocultures were characterized to identify genetic features associated with virulence (pathogenicity islands markers, phylogenetic group, virulence genes, plasmid profiles, and conjugative plasmids) and these results were compared with commensal isolates. The most prevalent pathogenicity island, in strains from hemoculture, were PAI IV536, described by many researchers as a stable island in enterobacteria. Among virulence genes, iutA gene was found more frequently and this gene enconding the aerobactin siderophore receptor. According to the phylogenetic classification, group B2 was the most commonly found. Additionally, through plasmid analysis, 14 isolates showed plasmids and 3 of these were shown to be conjugative. Although in stool samples of healthy people the presence of commensal strains is common, human intestinal tract may serve as a reservoir for ExPEC.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24822211 PMCID: PMC4009324 DOI: 10.1155/2014/465054
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Primers for detection of PAIs markers, phylogenetic analysis, virulence genes, and their respective virulence factors.
| Genes | Sequence (5′ to 3′) | Size of product (bp) | Virulence factors | Reference |
|---|---|---|---|---|
|
| TAA TGC CGG AGA TTC ATT GTC | 1.800 |
| Sabaté et al., 2006 [ |
|
| CAT GTC CAA AGC TCG AGC C | 1.000 |
| Sabaté et al., 2006 [ |
|
| AAG GAT TCG CTG TTA CCG GAC | 300 | Yersiniabactin siderophore system | Sabaté et al., 2006 [ |
|
| GGA CAT CCT GTT ACA GCG CGC A | 930 |
| Sabaté et al., 2006 [ |
|
| ATG GAT GTT GTA TCG CGC | 400 | P-fimbriae and iron-regulated genes | Sabaté et al., 2006 [ |
|
| TCG TGC TCA GGT CCG GAA TTT | 400 |
| Sabaté et al., 2006 [ |
|
| GGA TCC ATG AAA ACA TGG TTA ATG GG | 2.300 |
| Sabaté et al., 2006 [ |
|
| GAC GAA CCA ACG GTC AGG AT | 279 | Hemetransport in enterohemorrhagic O157:H7 | Clermont et al., 2000 [ |
|
| TGA AGT GTC AGG AGA CGC TG | 211 | Protein of function unknown | Clermont et al., 2000 [ |
| TSPE4.C2 | GAG TAA TGT CGG GGC ATT CA | 152 | Putative DNA fragment (TSPE4.C2) in | Clermont et al., 2000 [ |
|
| GCG CAT TTG CTG ATA CTG TTG | 272 | Capsule synthesis K1 e K5 |
Johnson and Stell, 2000 [ |
| K1 | TAG CAA ACG TTC TAT TGG TGC | 156 | Capsule K1 |
Johnson and Stell, 2000 [ |
|
| CAC ACA CAA ACG GGA GCT GTT | 680 | Colicin V |
Johnson and Stell, 2000 [ |
|
| GGC TGG ACA TCA TGG GAA CTG G | 302 | Aerobactin siderophore receptor | Johnson et al., 2008 [ |
|
| TGA TTA ACC CCG CGA CGG AA | 880 | Yersiniabactin |
Johnson and Stell, 2000 [ |
|
| GAC GGC TGT ACT GCA GGG TGT GGC G | 328 | P fimbriae |
Le Bouguénec et al., 1992 [ |
|
| CTG TAA TTA CGG AAG TGA TTT CTG | 1070 | P fimbriae |
Johnson and Stell, 2000 [ |
|
| CTC CGG AGA ACT GGG TGC ATC TTA C | 410 | Sfa fimbriae |
Le Bouguénec et al., 1992 [ |
|
| GTG GAT ACG ACG ATT ACT GTG | 240 | Sfa fimbriae |
Johnson and Stell, 2000 [ |
|
| GGC AGA GGG CCG GCA ACA GGC | 559 | M fimbriae |
Johnson and Stell, 2000 [ |
|
| AGG CAG GTG TGC GCC GCG TAC | 170 | Invasion of brain endothelium |
Johnson and Stell, 2000 [ |
|
| AAC AAG GAT AAG CAC TGT TCT GGC | 1.177 | Hemolysin |
Johnson and Stell, 2000 [ |
|
| AGG ATG GAG TTT CCT ATG CAG GAG | 498 | Cytotoxic necrotizing factor 1 |
Johnson and Stell, 2000 [ |
|
| AAT CTA ATT AAA GAG AAC | 543 | Cytotoxic necrotizing factor 2 |
Blanco et al., 1996 [ |
|
| GGT GTG GTG CGA TGA GCA CAG | 290 | Serum resistance |
Johnson and Stell, 2000 [ |
|
| AAT CCG GCA AAG AGA CGA ACC GCC T | 553 | Salmochelin siderophore receptor | Johnson et al., 2008 [ |
|
| TCA TCC CGG AAG CCT CCC TCA CTA CTA T | 496 | Episomal outer membrane protease | Johnson et al., 2008 [ |
|
| GGC CAC AGT CGT TTA GGG TGC TTA CC | 450 | Putative avian hemolysin | Johnson et al., 2008 [ |
|
| CAG CAA CCC GAA CCA CTT GAT G | 323 | Episomal increased serum survival | Johnson et al., 2008 [ |
Plasmid and resistance profile of strains from hemocultures.
| Strains | Plasmids | Molecular size of the plasmids (MDa) | Resistance profile |
|---|---|---|---|
| 1 | p1a | 78 | ApCbCfCmKnTr |
| 2 | p2a, b, c, d | 113, 112, 86, 82 | ApCbSmFoKnTr |
| 3 | p3a, b, c, d, e | 112, 99, 78, 58, 29 | ApCbCfCmSmFoGnKnSiSuTbTcTr |
| 4 | p4a | 59 | ApCfFoTcTr |
| 5 | p5a, b | 99, 71 | ApCbCfCmSmFoKnSuTcTr |
| 6 | p6a | 112 | ApCbCfCmSmFoGnKnSiTcTr |
| 7 | p7a | 99 | ApCbSmFoSu |
| 8 | NP | — | ApFo |
| 9 | NP | — | ApFo |
| 10 | p10a | 82 | ApCmFoTc |
| 11 | p11a | 68 | ApCbCmSmFo |
| 12 | NP | — | Ap |
| 13 | p13a, b, c, d, e | 87, 68, 59, 50, 29 | ApCbCfSmFoGnKnSuTbTcTr |
| 14 | p14a, b | 62, 44 | ApCbSm |
| 15 | NP | — | Ap |
| 16 | NP | — | Ap |
| 17 | p17a | 87 | ApCfCmSmKnTcTr |
| 18 | p18a | 62 | Ap |
| 19 | p19a | 92 | ApCbCmSmKnSuTcTr |
| 20 | NP | — | Ap |
NP: no plasmid; Ap: ampicillin; Cb: carbenicillin; Cf: cephalothin; Cm: chloramphenicol; Sm: streptomycin; Fo: fosfomycin; Gn: gentamicin; Kn: kanamycin; Si: sisomicin; Su: sulfonamide; Tb: tobramycin; Tc: tetracycline; Tr: trimethoprim.
Study of pathogenicity islands, phylogenetic classification, and virulence genes in 20 ExPEC strains from human hemocultures.
| Strains | PC | Pathogenicity islands | Virulence genes | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IV536 | ICFT073 | IICFT073 | IJ96 |
| K1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
| 1 | B2 | + | + | + | − | + | − | − | + | + | + | − | + | − | − | − | + | + | − | − | − |
| 2 | B2 | + | + | + | − | + | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − |
| 3 | B2 | + | + | − | − | + | + | − | − | − | − | − | − | − | − | − | + | − | − | − | − |
| 4 | B2 | − | − | − | + | + | + | − | − | − | − | + | − | − | − | − | + | − | − | − | − |
| 5 | A | − | − | − | − | − | − | − | − | − | − | − | − | − | − | + | − | + | + | + | + |
| 6 | A | − | − | − | − | − | − | − | + | + | − | − | − | − | − | + | + | + | − | − | − |
| 7 | B2 | + | + | − | − | + | − | + | + | + | − | − | + | − | − | + | + | + | − | − | − |
| 8 | B2 | + | + | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − |
| 9 | B2 | + | + | − | − | + | + | + | + | + | + | − | + | − | − | − | + | − | − | − | − |
| 10 | B1 | + | − | − | − | − | − | + | − | − | − | − | + | − | + | + | − | + | + | + | + |
| 11 | A | + | − | − | − | − | − | + | − | − | − | − | + | − | − | + | + | + | − | − | − |
| 12 | B1 | + | − | − | − | − | − | + | − | − | − | + | − | − | − | − | − | − | − | − | − |
| 13 | A | − | − | − | − | + | + | + | + | + | − | − | + | − | − | + | + | − | − | − | − |
| 14 | A | − | − | − | − | + | + | − | + | + | − | − | − | − | − | + | + | + | − | − | − |
| 15 | A | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | + | − | − | − | − |
| 16 | B2 | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | + | − | − | − |
| 17 | D | + | − | − | − | − | − | + | − | − | − | − | − | − | − | + | + | − | − | − | − |
| 18 | B1 | + | − | − | − | − | − | + | − | − | − | − | − | − | − | + | − | − | − | − | − |
| 19 | D | + | − | − | − | − | − | + | − | − | − | − | − | − | − | + | + | + | − | − | + |
| 20 | B1 | − | − | + | − | − | − | − | − | − | − | − | − | − | − | − | − | + | + | − | + |
PC: phylogenetic classification; pathogenicity islands: PAI IV536, PAI ICFT073, PAI IICFT073, and PAI IJ96; adhesions: papC, papG, sfaA, sfaS, and afa; invasion: ibe10; toxins: cnf2, cnf1, hlyA, hlyF, and cvaC; iron uptake systems: fyuA, iutA, and iroN; serum resistance: kps II, K1, traT, and iss; proteases: ompT.
Distribution of pathogenicity islands (PAI) according to phylogenetic classification (PC), among ExPEC and commensal strains.
| PC | PAI I536 | PAI II536 | PAI IV536 | PAI IJ96 | PAI ICFT073 | PAI IICFT073 | Total of PAIs | Total of strains |
|---|---|---|---|---|---|---|---|---|
| B2 (ExPEC) | 0 | 0 | 6 | 1 | 6 | 2 | 15 | 8 |
| B2 (commensal) | 0 | 0 | 2 | 0 | 2 | 1 | 5 | 6 |
| D (ExPEC) | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 2 |
| D (commensal) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| B1 (ExPEC) | 0 | 0 | 3 | 0 | 0 | 1 | 3 | 4 |
| B1 (commensal) | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 5 |
| A (ExPEC) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 6 |
| A (commensal) | 3 | 3 | 21 | 0 | 7 | 4 | 38 | 37 |
Genetic characterization of ExPEC transconjugants.
| Strains |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| − | − | − | − | − | − |
|
| + | + | − | + | + | + |
| 5.2 | + | + | − | + | + | + |
|
| − | + | + | − | − | − |
| 17.1 | − | + | + | − | − | − |
|
| + | + | − | − | − | − |
| 19.1 | − | + | − | − | − | − |
Serum resistance: iss and traT; iron uptake systems: iutA and iroN; proteases: ompT; toxin: hlyF.
Strains (donator of plasmids) = 5, 17, and 19; Tranconjugants = 5.2, 17.1, and 19.1.